The Exopolysaccharide Produced by <i>Lactobacillus paracasei</i> IJH-SONE68 Prevents and Ameliorates Inflammatory Responses in DSS–Induced Ulcerative Colitis
Inflammatory bowel disease (IBD) is an autoimmune disease characterized by chronic inflammation of the gastrointestinal tract. IBD includes Crohn’s disease (CD) and ulcerative colitis (UC). CD can occur in any part of the gastrointestinal tract, whereas UC mainly occurs in the colon and rectum. We p...
Guardado en:
Autores principales: | , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/57e3b4930f774e2a9be81957028c243e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:57e3b4930f774e2a9be81957028c243e |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:57e3b4930f774e2a9be81957028c243e2021-11-25T18:24:32ZThe Exopolysaccharide Produced by <i>Lactobacillus paracasei</i> IJH-SONE68 Prevents and Ameliorates Inflammatory Responses in DSS–Induced Ulcerative Colitis10.3390/microorganisms91122432076-2607https://doaj.org/article/57e3b4930f774e2a9be81957028c243e2021-10-01T00:00:00Zhttps://www.mdpi.com/2076-2607/9/11/2243https://doaj.org/toc/2076-2607Inflammatory bowel disease (IBD) is an autoimmune disease characterized by chronic inflammation of the gastrointestinal tract. IBD includes Crohn’s disease (CD) and ulcerative colitis (UC). CD can occur in any part of the gastrointestinal tract, whereas UC mainly occurs in the colon and rectum. We previously demonstrated that a novel exopolysaccharide (EPS) produced by a plant-derived bacterium, <i>Lactobacillus paracasei</i> IJH-SONE68, prevents and improves the inflammation in contact dermatitis model mice via oral administration. To evaluate the preventive effect of the EPS against other inflammatory diseases, in the present study, we employed dextran sulfate sodium (DSS)-induced UC model mice. The stool consistency, hematochezia, and colonic atrophy of the mice were improved by the orally administered EPS. We also evaluated the cytokine transcription. Overexpression of the mouse macrophage inflammatory protein 2 mRNA in the colon as a functional homolog of human interleukin-8 was decreased by the orally administered EPS. However, the expression of interleukin-10, which is known as an anti-inflammatory cytokine, was stimulated in the EPS-administrated group. Based on these results, we conclude that the IJH-SONE68-derived EPS is a promising lead material for the development of drugs useful in treating inflammatory diseases such as UC.Masafumi NodaNarandalai DanshiitsoodolKeishi KannoTomoyuki UchidaMasanori SugiyamaMDPI AGarticleinflammatory bowel disease (IBD)ulcerative colitis (UC)lactic acid bacteria (LAB)<i>Lactobacillus paracasei</i>exopolysaccharide (EPS)Biology (General)QH301-705.5ENMicroorganisms, Vol 9, Iss 2243, p 2243 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
inflammatory bowel disease (IBD) ulcerative colitis (UC) lactic acid bacteria (LAB) <i>Lactobacillus paracasei</i> exopolysaccharide (EPS) Biology (General) QH301-705.5 |
spellingShingle |
inflammatory bowel disease (IBD) ulcerative colitis (UC) lactic acid bacteria (LAB) <i>Lactobacillus paracasei</i> exopolysaccharide (EPS) Biology (General) QH301-705.5 Masafumi Noda Narandalai Danshiitsoodol Keishi Kanno Tomoyuki Uchida Masanori Sugiyama The Exopolysaccharide Produced by <i>Lactobacillus paracasei</i> IJH-SONE68 Prevents and Ameliorates Inflammatory Responses in DSS–Induced Ulcerative Colitis |
description |
Inflammatory bowel disease (IBD) is an autoimmune disease characterized by chronic inflammation of the gastrointestinal tract. IBD includes Crohn’s disease (CD) and ulcerative colitis (UC). CD can occur in any part of the gastrointestinal tract, whereas UC mainly occurs in the colon and rectum. We previously demonstrated that a novel exopolysaccharide (EPS) produced by a plant-derived bacterium, <i>Lactobacillus paracasei</i> IJH-SONE68, prevents and improves the inflammation in contact dermatitis model mice via oral administration. To evaluate the preventive effect of the EPS against other inflammatory diseases, in the present study, we employed dextran sulfate sodium (DSS)-induced UC model mice. The stool consistency, hematochezia, and colonic atrophy of the mice were improved by the orally administered EPS. We also evaluated the cytokine transcription. Overexpression of the mouse macrophage inflammatory protein 2 mRNA in the colon as a functional homolog of human interleukin-8 was decreased by the orally administered EPS. However, the expression of interleukin-10, which is known as an anti-inflammatory cytokine, was stimulated in the EPS-administrated group. Based on these results, we conclude that the IJH-SONE68-derived EPS is a promising lead material for the development of drugs useful in treating inflammatory diseases such as UC. |
format |
article |
author |
Masafumi Noda Narandalai Danshiitsoodol Keishi Kanno Tomoyuki Uchida Masanori Sugiyama |
author_facet |
Masafumi Noda Narandalai Danshiitsoodol Keishi Kanno Tomoyuki Uchida Masanori Sugiyama |
author_sort |
Masafumi Noda |
title |
The Exopolysaccharide Produced by <i>Lactobacillus paracasei</i> IJH-SONE68 Prevents and Ameliorates Inflammatory Responses in DSS–Induced Ulcerative Colitis |
title_short |
The Exopolysaccharide Produced by <i>Lactobacillus paracasei</i> IJH-SONE68 Prevents and Ameliorates Inflammatory Responses in DSS–Induced Ulcerative Colitis |
title_full |
The Exopolysaccharide Produced by <i>Lactobacillus paracasei</i> IJH-SONE68 Prevents and Ameliorates Inflammatory Responses in DSS–Induced Ulcerative Colitis |
title_fullStr |
The Exopolysaccharide Produced by <i>Lactobacillus paracasei</i> IJH-SONE68 Prevents and Ameliorates Inflammatory Responses in DSS–Induced Ulcerative Colitis |
title_full_unstemmed |
The Exopolysaccharide Produced by <i>Lactobacillus paracasei</i> IJH-SONE68 Prevents and Ameliorates Inflammatory Responses in DSS–Induced Ulcerative Colitis |
title_sort |
exopolysaccharide produced by <i>lactobacillus paracasei</i> ijh-sone68 prevents and ameliorates inflammatory responses in dss–induced ulcerative colitis |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/57e3b4930f774e2a9be81957028c243e |
work_keys_str_mv |
AT masafuminoda theexopolysaccharideproducedbyilactobacillusparacaseiiijhsone68preventsandamelioratesinflammatoryresponsesindssinducedulcerativecolitis AT narandalaidanshiitsoodol theexopolysaccharideproducedbyilactobacillusparacaseiiijhsone68preventsandamelioratesinflammatoryresponsesindssinducedulcerativecolitis AT keishikanno theexopolysaccharideproducedbyilactobacillusparacaseiiijhsone68preventsandamelioratesinflammatoryresponsesindssinducedulcerativecolitis AT tomoyukiuchida theexopolysaccharideproducedbyilactobacillusparacaseiiijhsone68preventsandamelioratesinflammatoryresponsesindssinducedulcerativecolitis AT masanorisugiyama theexopolysaccharideproducedbyilactobacillusparacaseiiijhsone68preventsandamelioratesinflammatoryresponsesindssinducedulcerativecolitis AT masafuminoda exopolysaccharideproducedbyilactobacillusparacaseiiijhsone68preventsandamelioratesinflammatoryresponsesindssinducedulcerativecolitis AT narandalaidanshiitsoodol exopolysaccharideproducedbyilactobacillusparacaseiiijhsone68preventsandamelioratesinflammatoryresponsesindssinducedulcerativecolitis AT keishikanno exopolysaccharideproducedbyilactobacillusparacaseiiijhsone68preventsandamelioratesinflammatoryresponsesindssinducedulcerativecolitis AT tomoyukiuchida exopolysaccharideproducedbyilactobacillusparacaseiiijhsone68preventsandamelioratesinflammatoryresponsesindssinducedulcerativecolitis AT masanorisugiyama exopolysaccharideproducedbyilactobacillusparacaseiiijhsone68preventsandamelioratesinflammatoryresponsesindssinducedulcerativecolitis |
_version_ |
1718411196389916672 |